article thumbnail

STAT+: House panel expected to mark up pandemic-preparedness bill next week

STAT

WASHINGTON — A House subcommittee will next week mark up a package of public health bills, including pandemic-preparedness legislation, according to five lobbyists. The House Energy & Commerce Committee hasn’t yet announced the markup, and the lobbyists didn’t know the exact date.

Packaging 246
article thumbnail

Health Insurance Startup CEOs’ Sky-High Compensation Figures Are Deceiving

Drug Channels

Leslie and Jinghong discuss the terms of health insurance startups CEOs’ compensation packages. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. They explain why the reported CEO total compensation numbers are deceiving. Access the full findings from AIS’ Healthcare Executive Compensation Survey here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sandoz receives approval by EC for Hyrimoz® high-concentration formulation

LifeProNow

As part of the comprehensive submission package to the European Marketing Authorization, Sandoz conducted a Phase I pharmacokinetics (PK) bridging study comparing its approved adalimumab 50 mg/mL 2 with the 100 mg/mL (HCF). It has a leading global portfolio with eight marketed biosimilars and a further 15+ in various stages of development.

article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake. References.

Dosage 98
article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

The ISMP gives a history of the list in a newsletter published shortly after it was removed from their website : The List of Oral Dosage Forms That Should Not Be Crushed (commonly referred to as the Do Not Crush List) was first posted on ISMP’s website in 2006 (www.ismp.org/node/140).

Dosage 111
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

It is too early to say because we have not seen the whole package of measures yet. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006. The cost of opportunity – A study on pharmaceutical R&D costs [Internet].

article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

Launch of the EU pharmaceutical package The European Commission plans to commence initiatives relating to the European Pharmaceutical Strategy (strategy) with the publication of the revised EU pharmaceutical package scheduled during the first quarter of 2023.

Packaging 117